A study from the University of Oxford has warned that the Pfizer Covid-19 vaccine becomes significantly less effective against the Delta variant just four months after the second dose - although it still offers some protection. The...
Full ArticleCovid-19 Coronavirus: Pfizer effectiveness falls after three months, study shows
New Zealand Herald
0 shares
2 views
You might like
Related news coverage
U.S. Regulators Give Full Approval to Pfizer COVID-19 Vaccine
Newsy
Watch VideoThe U.S. gave full approval to Pfizer's COVID-19 vaccine on Monday, a milestone that may help lift public confidence in..
-
NA Proactive news snapshot: Alpine 4 Holdings, EVmo, Recruiter.com Group, Belmont Resources, HempFusion Wellness UPDATE ...
Proactive Investors
-
NA Proactive news snapshot: Recruiter.com Group, Belmont Resources, HempFusion Wellness, Pure Gold Mining, Canada Silver Cobalt Works UPDATE ...
Proactive Investors
-
DESIGNED TO FAIL: Pfizer's covid vaccine plunges to only 42 percent effectiveness against new infections, empowering push for yet more "booster" shots
NaturalNews.com
-
NA Proactive news snapshot: Vuzix, Western Magnesium, Logiq, Sanatana Resources, Water Tower Research, Sanatana Resources UPDATE ...
Proactive Investors
Advertisement
More coverage
APEC Forum Leaders’ Meeting Reaffirms Commitment To Close Collaboration – Analysis
Eurasia Review
The leaders of the economies of the Asia-Pacific Economic Cooperation Forum adopted a joint statement following an extraordinary..
-
Paradigm Biopharmaceuticals' pre-clinical food study in chronic heart failure continues ahead of commentary in Q4
Proactive Investors
-
Novavax seeks COVID-19 vaccine use in India ahead of US
SeattlePI.com
-
NA Proactive news snapshot: Falcon Gold, Water Tower Research, African Gold, Levitee Labs, Gevo UPDATE ...
Proactive Investors
-
NA Proactive news snapshot: Levitee Labs, Gevo, Spotlite360 Technologies, Japan Gold, ESE Entertainment, PlantX Life UPDATE ...
Proactive Investors